Drugs / Autologous renal cell vaccine based on DNP modified cells
Autologous renal cell vaccine based on DNP modified cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00890110 | Jun 2009 → Jun 2011 | renal cell carcinoma | Hadassah Medical Organization | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous renal cell vaccine based on DNP modified cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00890110 ↗ |
| Modality | Vaccine | “Vaccination with autologous cellular vaccines of RCC patients will induce clinical and immunological responses” NCT00890110 ↗ |